In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

被引:4
|
作者
Pu Y. [1 ]
Liu H. [1 ]
Zhou Y. [1 ]
Peng J. [1 ]
Li Y. [1 ]
Li P. [1 ]
Li Y. [1 ]
Liu X. [1 ]
Zhang L. [1 ]
机构
[1] School of Chemical Engineering, Sichuan University of Science & Engineering, Zigong
关键词
Docking; FXa; Pharmacophore; Thrombotic diseases;
D O I
10.1007/s13659-017-0126-x
中图分类号
学科分类号
摘要
Abstract: Coagulation Factor Xa (FXa) is the crucial enzyme at the convergent point of the intrinsic and extrinsic coagulation pathways. The inhibition of FXa is an effective approach against thrombotic diseases. In the present study, a specific strategy is reported to discover 10 novel FXa inhibitors based on ligand-based (pharmacophore) virtual screening and molecular docking analysis from a dataset of specs(containing 220000 molecules). The binding modes analysis provide insights into the contribution of particular structural moieties of the compounds towards their activity against FXa, and 10 novel structural compounds were discovered as potent candidate molecules. This work could be helpful in further design and development of FXa inhibitors. Graphical Abstract: [Figure not available: see fulltext.]. © 2017, The Author(s).
引用
收藏
页码:249 / 256
页数:7
相关论文
共 50 条
  • [31] Pharmacophore identification, docking and "in silico" screening for novel CDK1 inhibitors
    Dong, Xiaowu
    Yan, Jingying
    Du, Lilin
    Wu, Peng
    Huang, Shufang
    Liu, Tao
    Hu, Yongzhou
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2012, 37 : 77 - 86
  • [32] In silico Studies Toward the Discovery of Novel Type-II Inhibitors of TrkA: Pharmacophore-based 3D-QSAR Modeling, Database Screening and Molecular Docking
    Tian, Yahui
    Zhou, Lu
    Li, Xiaoli
    Zhou, Suwen
    Yong, Rong
    Zhong, Liangliang
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2016, 13 (06) : 526 - 538
  • [33] 3D-Pharmacophore Modeling, Molecular Docking, and Virtual Screening for Discovery of Novel CDK4/6 Selective Inhibitors
    Amany Belal
    [J]. Russian Journal of Bioorganic Chemistry, 2021, 47 : 317 - 333
  • [34] 3D-Pharmacophore Modeling, Molecular Docking, and Virtual Screening for Discovery of Novel CDK4/6 Selective Inhibitors
    Belal, Amany
    [J]. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2021, 47 (01) : 317 - 333
  • [35] Discovery of novel natural products as dual MNK/PIM inhibitors for acute myeloid leukemia treatment: Pharmacophore modeling, molecular docking, and molecular dynamics studies
    Mohamed, Linda M.
    Eltigani, Maha M.
    Abdallah, Marwa H.
    Ghaboosh, Hiba
    Bin Jardan, Yousef A.
    Yusuf, Osman
    Elsaman, Tilal
    Mohamed, Magdi A.
    Alzain, Abdulrahim A.
    [J]. FRONTIERS IN CHEMISTRY, 2022, 10
  • [36] Discovery of new dual binding TNKS inhibitors of Wnt signaling inhibition by pharmacophore modeling, molecular docking and bioassay
    Pu, Yinglan
    Zhang, Shuqun
    Chang, Zhe
    Zhang, Yunqin
    Wang, Dong
    Zhang, Li
    Li, Yan
    Zuo, Zhili
    [J]. MOLECULAR BIOSYSTEMS, 2017, 13 (02) : 363 - 370
  • [37] In Silico Design of Human IMPDH Inhibitors Using Pharmacophore Mapping and Molecular Docking Approaches
    Li, Rui-Juan
    Wang, Ya-Li
    Wang, Qing-He
    Wang, Jian
    Cheng, Mao-Sheng
    [J]. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2015, 2015
  • [38] SBDD of novel FXA inhibitors: Using the crystal structures of human fxa complexed with our novel inhibitors and new pharmacophore.
    Matsusue, T
    Shiromizu, I
    Nishida, H
    Mukaihira, T
    Saitoh, F
    Hosaka, Y
    Morishita, H
    Mochizuki, H
    Ohnishi, S
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U954 - U954
  • [39] Discovery of novel covalent proteasome inhibitors through a combination of pharmacophore screening, covalent docking, and molecular dynamics simulations
    Li, Aibo
    Sun, Haopeng
    Du, Lei
    Wu, Xiaoxin
    Cao, Jianqin
    You, Qidong
    Li, Yuyan
    [J]. JOURNAL OF MOLECULAR MODELING, 2014, 20 (11) : 1 - 13
  • [40] Discovery of novel covalent proteasome inhibitors through a combination of pharmacophore screening, covalent docking, and molecular dynamics simulations
    Aibo Li
    Haopeng Sun
    Lei Du
    Xiaoxin Wu
    Jianqin Cao
    Qidong You
    Yuyan Li
    [J]. Journal of Molecular Modeling, 2014, 20